The pharmacology and therapeutic potential of plant cannabinoids

Maria Grazia Cascio, Roger G Pertwee, Pietro Marini

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

The plant Cannabis sativa has been widely used by humans over many centuries as a source of fibre, for medicinal purposes, for religious ceremonies and as a recreational drug. Since the discovery of its main psychoactive ingredient, Δ9-tetrahydrocannabinol (THC), significant progress has been made towards the understanding (1) of the in vitro and in vivo pharmacology both of THC and of certain other cannabis-derived compounds, and (2) of the potential and actual uses of these “phytocannabinoids” as medicines. There is now extensive evidence that the pharmacological effects of some widely-studied phytocannabinoids, are due to their ability to interact with cannabinoid receptors and/or with other kinds of pharmacological targets, including non-cannabinoid receptors, and this makes the pharmacology of the phytocannabinoids rather complex and interesting. In this chapter, we provide an overview of the in vitro pharmacology of five selected phytocannabinoids and report findings that have identified potential new therapeutic uses for these compounds.


Original languageEnglish
Title of host publicationCannabis sativa L. - Botany and Biotechnology
EditorsS. Chandra, H. Lata, M.A. ElSohly
PublisherSpringer, Biomedicine & Life Sciences
Pages207-225
Number of pages19
ISBN (Electronic)978-3-319-54564-6
ISBN (Print)978-3-319-54563-9
DOIs
Publication statusPublished - 2017

Fingerprint

Cannabinoids
Pharmacology
Dronabinol
Therapeutics
Cannabinoid Receptors
Street Drugs
Therapeutic Uses
Cannabis

Keywords

  • Mouse Brain Membrane
  • House Musk Shrew
  • TRPM8 Cation Channel
  • Cannabidiolic Acid
  • TRPV3 Cation Channel

Cite this

Cascio, M. G., Pertwee, R. G., & Marini, P. (2017). The pharmacology and therapeutic potential of plant cannabinoids. In S. Chandra, H. Lata, & M. A. ElSohly (Eds.), Cannabis sativa L. - Botany and Biotechnology (pp. 207-225). Springer, Biomedicine & Life Sciences. https://doi.org/10.1007/978-3-319-54564-6_9

The pharmacology and therapeutic potential of plant cannabinoids. / Cascio, Maria Grazia; Pertwee, Roger G; Marini, Pietro.

Cannabis sativa L. - Botany and Biotechnology. ed. / S. Chandra; H. Lata; M.A. ElSohly. Springer, Biomedicine & Life Sciences, 2017. p. 207-225.

Research output: Chapter in Book/Report/Conference proceedingChapter

Cascio, MG, Pertwee, RG & Marini, P 2017, The pharmacology and therapeutic potential of plant cannabinoids. in S Chandra, H Lata & MA ElSohly (eds), Cannabis sativa L. - Botany and Biotechnology. Springer, Biomedicine & Life Sciences, pp. 207-225. https://doi.org/10.1007/978-3-319-54564-6_9
Cascio MG, Pertwee RG, Marini P. The pharmacology and therapeutic potential of plant cannabinoids. In Chandra S, Lata H, ElSohly MA, editors, Cannabis sativa L. - Botany and Biotechnology. Springer, Biomedicine & Life Sciences. 2017. p. 207-225 https://doi.org/10.1007/978-3-319-54564-6_9
Cascio, Maria Grazia ; Pertwee, Roger G ; Marini, Pietro. / The pharmacology and therapeutic potential of plant cannabinoids. Cannabis sativa L. - Botany and Biotechnology. editor / S. Chandra ; H. Lata ; M.A. ElSohly. Springer, Biomedicine & Life Sciences, 2017. pp. 207-225
@inbook{e19a23dcf84d4163b3b0fee4baa37a9a,
title = "The pharmacology and therapeutic potential of plant cannabinoids",
abstract = "The plant Cannabis sativa has been widely used by humans over many centuries as a source of fibre, for medicinal purposes, for religious ceremonies and as a recreational drug. Since the discovery of its main psychoactive ingredient, Δ9-tetrahydrocannabinol (THC), significant progress has been made towards the understanding (1) of the in vitro and in vivo pharmacology both of THC and of certain other cannabis-derived compounds, and (2) of the potential and actual uses of these “phytocannabinoids” as medicines. There is now extensive evidence that the pharmacological effects of some widely-studied phytocannabinoids, are due to their ability to interact with cannabinoid receptors and/or with other kinds of pharmacological targets, including non-cannabinoid receptors, and this makes the pharmacology of the phytocannabinoids rather complex and interesting. In this chapter, we provide an overview of the in vitro pharmacology of five selected phytocannabinoids and report findings that have identified potential new therapeutic uses for these compounds.",
keywords = "Mouse Brain Membrane, House Musk Shrew, TRPM8 Cation Channel, Cannabidiolic Acid, TRPV3 Cation Channel",
author = "Cascio, {Maria Grazia} and Pertwee, {Roger G} and Pietro Marini",
year = "2017",
doi = "10.1007/978-3-319-54564-6_9",
language = "English",
isbn = "978-3-319-54563-9",
pages = "207--225",
editor = "S. Chandra and H. Lata and M.A. ElSohly",
booktitle = "Cannabis sativa L. - Botany and Biotechnology",
publisher = "Springer, Biomedicine & Life Sciences",

}

TY - CHAP

T1 - The pharmacology and therapeutic potential of plant cannabinoids

AU - Cascio, Maria Grazia

AU - Pertwee, Roger G

AU - Marini, Pietro

PY - 2017

Y1 - 2017

N2 - The plant Cannabis sativa has been widely used by humans over many centuries as a source of fibre, for medicinal purposes, for religious ceremonies and as a recreational drug. Since the discovery of its main psychoactive ingredient, Δ9-tetrahydrocannabinol (THC), significant progress has been made towards the understanding (1) of the in vitro and in vivo pharmacology both of THC and of certain other cannabis-derived compounds, and (2) of the potential and actual uses of these “phytocannabinoids” as medicines. There is now extensive evidence that the pharmacological effects of some widely-studied phytocannabinoids, are due to their ability to interact with cannabinoid receptors and/or with other kinds of pharmacological targets, including non-cannabinoid receptors, and this makes the pharmacology of the phytocannabinoids rather complex and interesting. In this chapter, we provide an overview of the in vitro pharmacology of five selected phytocannabinoids and report findings that have identified potential new therapeutic uses for these compounds.

AB - The plant Cannabis sativa has been widely used by humans over many centuries as a source of fibre, for medicinal purposes, for religious ceremonies and as a recreational drug. Since the discovery of its main psychoactive ingredient, Δ9-tetrahydrocannabinol (THC), significant progress has been made towards the understanding (1) of the in vitro and in vivo pharmacology both of THC and of certain other cannabis-derived compounds, and (2) of the potential and actual uses of these “phytocannabinoids” as medicines. There is now extensive evidence that the pharmacological effects of some widely-studied phytocannabinoids, are due to their ability to interact with cannabinoid receptors and/or with other kinds of pharmacological targets, including non-cannabinoid receptors, and this makes the pharmacology of the phytocannabinoids rather complex and interesting. In this chapter, we provide an overview of the in vitro pharmacology of five selected phytocannabinoids and report findings that have identified potential new therapeutic uses for these compounds.

KW - Mouse Brain Membrane

KW - House Musk Shrew

KW - TRPM8 Cation Channel

KW - Cannabidiolic Acid

KW - TRPV3 Cation Channel

U2 - 10.1007/978-3-319-54564-6_9

DO - 10.1007/978-3-319-54564-6_9

M3 - Chapter

SN - 978-3-319-54563-9

SP - 207

EP - 225

BT - Cannabis sativa L. - Botany and Biotechnology

A2 - Chandra, S.

A2 - Lata, H.

A2 - ElSohly, M.A.

PB - Springer, Biomedicine & Life Sciences

ER -